Literature DB >> 11708478

Detection of mammaglobin mRNA in the plasma of breast cancer patients.

S Gal1, C Fidler, Y M Lo, K Chin, J Moore, A L Harris, J S Wainscoat.   

Abstract

It has been suggested that mammaglobin may be a useful marker for breast cancer clinical research. Studies investigating the detection of mRNA by RT-PCR from circulating carcinoma cells in the peripheral blood of breast cancer patients have shown that mammaglobin is a highly specific marker and correlates with several prognostic factors, such as lymph node involvement. We aimed to detect cell-free mammaglobin mRNA in the plasma of breast cancer patients and to investigate whether it can be used as a marker for diagnosis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708478     DOI: 10.1111/j.1749-6632.2001.tb03885.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.

Authors:  Akemi Sato; Naoko Sueoka-Aragane; Juichi Saitoh; Kazutoshi Komiya; Takashi Hisatomi; Rika Tomimasu; Shinichiro Hayashi; Eisaburo Sueoka
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-07       Impact factor: 4.553

2.  Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.

Authors:  Sana Sahengbieke; Jian Wang; Xiangwei Li; Yuhong Wang; Maode Lai; Jingjing Wu
Journal:  J Clin Lab Anal       Date:  2017-09-26       Impact factor: 2.352

3.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

4.  Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.

Authors:  Ida Casciano; Angela Di Vinci; Barbara Banelli; Claudio Brigati; Alessandra Forlani; Giorgio Allemanni; Massimo Romani
Journal:  Breast Care (Basel)       Date:  2010-04-23       Impact factor: 2.860

5.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 6.  Circulating RNAs as new biomarkers for detecting pancreatic cancer.

Authors:  Takahiro Kishikawa; Motoyuki Otsuka; Motoko Ohno; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

7.  Serum messenger RNA as a biomarker and its clinical usefulness in malignancies.

Authors:  Norimasa Miura; Junichi Hasegawa; Goshi Shiota
Journal:  Clin Med Oncol       Date:  2008-09-22

8.  A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection.

Authors:  Matthew H Larson; Wenying Pan; Hyunsung John Kim; Ruth E Mauntz; Sarah M Stuart; Monica Pimentel; Yiqi Zhou; Per Knudsgaard; Vasiliki Demas; Alexander M Aravanis; Arash Jamshidi
Journal:  Nat Commun       Date:  2021-04-21       Impact factor: 17.694

Review 9.  Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy.

Authors:  Germana Rappa; Caterina Puglisi; Mark F Santos; Stefano Forte; Lorenzo Memeo; Aurelio Lorico
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.